Assessment of Trunk Control and Postural Instability in Patients With Various Neurological Disorders (Stroke, Parkinson, Sclerosis Multiplex) Using Objective Tools (TecnoBody ProKin Posturometry, 3D Motion Analysis)

NCT07411664 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-17

No results posted yet for this study

Summary

Nowadays, stroke is one of the most common leading causes of death in many countries. As the number of stroke patients is increasing, even in younger age groups, there is an increasing need to improve their rehabilitation. In order for this process to start, it is inevitable to integrate the latest recommendations of health and sports science into rehabilitation, in addition to medicine, so that the treatment is as complex as possible. Parkinson's disease is one of the most common neurological diseases, in addition to stroke. The most significant damage can be experienced in motor functions, since one of the main symptoms of the disease is slowed movement, tremor and balance disorders. This postural change can lead to many other musculoskeletal changes, which is why Parkinson's disease is an extremely complex disease that also requires a complex treatment. The third disease examined in our research is multiple sclerosis (MS), which is also one of the most significant nervous system diseases, with nearly 1 million cases registered so far. The most common symptoms of MS patients are weakness, numbness, dizziness, coordination and balance disorders, as well as changes and uncertainty in the gait pattern. One of the essential foundations of rehabilitation after neurological diseases is neurorehabilitation, since the process will only be truly effective if cognitive and motor functions are developed in parallel. In the case of neurological diseases, as we can see above, one of the most significant symptoms is coordination and balance disorders. When the nervous system is affected, trunk control and the patient's posture will always change, depending on the given disease and the individual. One of the fundamental goals of rehabilitation should be to develop stability and postural control, because without these, we will not be able to effectively develop and restore the patients' significant motor functions. This is why it is important that neurological patients are assessed from this perspective as early as possible, so that their treatment plan can be adapted to their disease and themselves as much as possible.

Conditions

Interventions

DEVICE

Stroke posturo/3D group

The Tecnobody ProKin stabilometer and posturometer is currently one of the most effective tools for objectively measuring static and dynamic balance. It can effectively measure the trunk control and sense of balance of patients in several ways: on stable or unstable surfaces, and while standing on one or two legs. With the help of various programs, the device determines the oscillations of the center of mass (CoP) of the patient's body, and is able to accurately determine the patient's proprioceptive perception. Furthermore, ProKin is able to examine the joint movements of the trunk and lower limbs together or even separately. Thanks to these quantified data, we have the opportunity to map the postural instability and balance disorders caused by different patient groups, and thus we will be able to provide a more accurate treatment for our patients. With 3D motion analysis stride length, stride width and the number of steps in 10 meters were measured.

DEVICE

Parkinson posturo/3D group

The Tecnobody ProKin stabilometer and posturometer is currently one of the most effective tools for objectively measuring static and dynamic balance. It can effectively measure the trunk control and sense of balance of patients in several ways: on stable or unstable surfaces, and while standing on one or two legs. With the help of various programs, the device determines the oscillations of the center of mass (CoP) of the patient's body, and is able to accurately determine the patient's proprioceptive perception. Furthermore, ProKin is able to examine the joint movements of the trunk and lower limbs together or even separately. Thanks to these quantified data, we have the opportunity to map the postural instability and balance disorders caused by different patient groups, and thus we will be able to provide a more accurate treatment for our patients. With 3D motion analysis stride length, stride width and the number of steps in 10 meters were measured.

DEVICE

Multiple sclerosis posturo/3D group

The Tecnobody ProKin stabilometer and posturometer is currently one of the most effective tools for objectively measuring static and dynamic balance. It can effectively measure the trunk control and sense of balance of patients in several ways: on stable or unstable surfaces, and while standing on one or two legs. With the help of various programs, the device determines the oscillations of the center of mass (CoP) of the patient's body, and is able to accurately determine the patient's proprioceptive perception. Furthermore, ProKin is able to examine the joint movements of the trunk and lower limbs together or even separately. Thanks to these quantified data, we have the opportunity to map the postural instability and balance disorders caused by different patient groups, and thus we will be able to provide a more accurate treatment for our patients. With 3D motion analysis stride length, stride width and the number of steps in 10 meters were measured.

Sponsors & Collaborators

  • Somogy Megyei Kaposi Mór Teaching Hospital

    lead OTHER

Principal Investigators

  • József Dr. Tollár · Somogy County Kaposi Mór Teaching Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2027-03-01
Completion
2028-03-01

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07411664 on ClinicalTrials.gov